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The topical application of a medicament vehicle consisting of a compress, poultice, plaster, and tape containing a nonsteroidal
anti-inﬂammatory drug or methyl salicylate is prevalent in Japan. The method is eﬀective for conveying ingredients to the muscles
via the skin for the relief of muscular pain. However, an ingredient in the occlusive vehicle can cause allergic and photoallergic
contact dermatitis. We summarize cases reported over the past decade and discuss the current strategy for diminishing the risk of
allergic and photoallergic contact dermatitis.
1.Introduction
The application of a topical medicament consisting of a
compress, poultice, plaster, and tape is prevalent in Japan.
The occlusive vehicle is eﬀective for conveying ingredients
to the muscles via the skin. The vehicle usually contains
a nonsteroidal anti-inﬂammatory drug (NSAID) or methyl
salicylate as the eﬀective component. It may also contain
dl-camphor for relief of peripheral pain, l-menthol for
peripheral cooling, and other ingredients, such as paraben,
modiﬁed rosin, oxybenzone, and diisopropanolamine. We
summarize cases of allergic and photoallergic contact der-
matitis from an ingredient that were reported during the last
decade [1–15].
2.AllergicandPhotoallergic
ContactDermatitis
The occlusive application enhances the penetration of the
eﬀective substances. However, increased penetration may
provoke allergic and photoallergic contact dermatitis from
an ingredient. Allergic and photoallergic sensitization to two
or more allergic or photoallergic substances can simultane-
ously occur [2, 6, 12]. Patch and photopatch testing with all
of components is indispensable for precise diagnosis.
The eﬀective components, an NSAID [6]o rm e t h y ls a l i -
cylate [8], have been shown to be allergens. Additives, such
as crotamiton [6], diisopropanolamine [6, 10, 15], l-menthol
[12, 14], paraben [7], and modiﬁed resin [11, 12] also have
been shown to be allergens. Benzalkonium chloride usually
inducesirritantcontactdermatitis,butrarelyinducesallergic
contact dermatitis [5, 16–18].
Ingredients such as ketoprofen [1–4, 12] and oxybenzone
[2] have been shown to be photoallergens. The most haza-
rdous is ketoprofen because of the highly frequent occurre-
nce of photoallergic contact dermatitis [1–4, 12]. The mouse
model of photoallergic contact dermatitis from ketoprofen
hasbeenestablishedandthepathogenicmechanismhasbeen
investigated [19, 20].
The clinical feature is typically eczematous reactions,
pruritic papular, vesicular, and bullous appearance. The size
and shape are dictated by those of the applied vehicle, which
is generally rectangular. Case 1 was a 68-year-old Japanese
woman with a rectangular pruritic erythematous macular
area on the right knee (Figure 1)[ 7]. In Case 1, patch testing
showed a positive reaction at day 2 and 4 to the methyl and2 Journal of Allergy
Figure1:A68-year-oldJapanesewomanwitharectangularpruritic
erythematous macular area on the right knee.
Methyl paraben 5% pet.
Propyl paraben 5% pet.
Figure 2: Patch testing for Case 1 showed positive reactions to
methyl and propyl paraben at day 4.
propylparabencontainedinthecompressthathadbeenused
(Figure 2)[ 7].
Some cases may show a rectangular eruption with a dif-
fuse erythematous [6] or erythema multiform-like gener-
alized reaction [14]. Case 2 was an 87-year-old Japanese
male with a rectangular erythema on the bilateral lower
back and the buttock and a diﬀuse erythema on the trunk
and extremities caused by allergic contact dermatitis from
the diisopropanolamine in the compresses that he used
(Figure 3)[ 15].
Rectangular pruritic erythema may occur only when the
lesion is exposed to sunlight. The eﬀective component of
the NSAID, such as ketoprofen, causes photoallergic contact
dermatitis [1–4, 12, 13]. In such cases, a rectangular-shaped
dermatitis with spreading [1] or erythema multiform-like
eruption [13] is seen. Photoallergic contact dermatitis can
be evoked by exposure to sunlight several weeks later
after stopping the use of the occlusive products containing
ketoprofen, because even several weeks after discontinuing
the use of a poultice containing ketoproten, the skin still
contains enough ketoprofen to trigger a reaction [1].
Figure 3: An 87-year-old Japanese male with rectangular erythema
on the bilateral lower back and buttocks and a diﬀuse erythema on
the trunk and extremities.
Strategies to diminish the risk of allergic and photoaller-
gic contact dermatitis are promoted. One is the use of a top-
ical cream, gel, or stick containing a low-sensitizing NSAID,
such as felbinac [6] or loxoprofen. Another is the use of a
topical occlusive medicament containing a low-sensitizing
NSAID. However, physicians and pharmacologists must
keep in mind that systemic contact and photocontact-type
dermatitis may be evoked if a person previously sensitized to
an NSAID orally takes the same NSAID [21].
In conclusion, the application of a vehicle consisting of
a compress, poultice, plaster, and tape carries a greater risk
of sensitization and elicitation of allergic and photoallergic
contact dermatitis from an ingredient. For safety, we initially
recommend the use of a topical cream, gel, or stick contain-
ing a less sensitizing ingredient, and secondarily a topical
occlusive medicament containing a less sensitizing NSAID.
Conﬂict of Interests
None declared.
References
[1] M.Sugiura,R.Hayakawa, Y.Kato,K.Sugiura,andH.Ueda,“4
cases of photocontact dermatitis due to ketoprofen,” Contact
Dermatitis, vol. 43, no. 1, pp. 16–19, 2000.
[2] A. Kawada, Y. Aragane, M. Asai, and T. Tezuka, “Simultaneous
photocontact sensitivity to ketoprofen and oxybenzone,”
Contact Dermatitis, vol. 44, no. 6, p. 370, 2001.
[3] M. Sugiyama, T. Nakada, H. Hosaka, H. Sueki, and M. Iijima,
“Photocontact dermatitis to ketoprofen,” American Journal of
Contact Dermatitis, vol. 12, no. 3, pp. 180–181, 2001.
[4] T. Matsushita and R. Kamide, “Five cases of photocontact
dermatitis due to topical ketoprofen: photopatch testing
and cross-reaction study,” Photodermatology Photoimmunol-
ogy and Photomedicine, vol. 17, no. 1, pp. 26–31, 2001.Journal of Allergy 3
[5] D. A. Wong and A. B. Watson, “Allergic contact dermatitis
due to benzalkonium chloride in plaster of Paris,” Australasian
Journal of Dermatology, vol. 42, no. 1, pp. 33–35, 2001.
[6] N. Oiso, K. Fukai, and M. Ishii, “Triple allergic contact sensi-
tivities due to ferbinac, crotamiton and diisopropanolamine,”
Contact Dermatitis, vol. 49, no. 5, pp. 261–263, 2003.
[7] N. Oiso, K. Fukai, and M. Ishii, “Allergic contact dermatitis
caused by parabens in a compress,” Contact Dermatitis, vol.
50, no. 5, p. 317, 2004.
[8] N. Oiso, K. Fukai, and M. Ishii, “Allergic contact dermatitis
due to methyl salicylate in a compress,” Contact Dermatitis,
vol. 51, no. 1, pp. 34–35, 2004.
[9] M. Rademaker, “Allergic contact dermatitis to a sanitary pad,”
Australasian Journal of Dermatology, vol. 45, no. 4, pp. 234–
235, 2004.
[10] Y. Umebayashi, “Two cases of contact dermatitis due to
diisopropanolamine,” Journal of Dermatology, vol. 32, no. 2,
pp. 145–146, 2005.
[ 1 1 ] C .F o t i ,D .B o n a m o n t e ,A .C o n s e r v a ,C .C a s u l l i ,a n d
G. Angelini, “Allergic contact dermatitis to glyceryl-
hydrogenated rosinate in a topical plaster,”Contact Dermatitis,
vol. 55, no. 2, pp. 120–121, 2006.
[12] T. Ota, N. Oiso, Y. Iba, T. Narita, S. Kawara, and A.
Kawada, “Concomitant development of photoallergic contact
dermatitis from ketoprofen and allergic contact dermatitis
from menthol and rosin (colophony) in a compress,” Contact
Dermatitis, vol. 56, no. 1, pp. 47–48, 2007.
[13] K. Izu, R. Hino, H. Isoda, D. Nakashima, K. Kabashima, and
Y. Tokura, “Photocontact dermatitis to ketoprofen presenting
with erythema multiforme,” European Journal of Dermatology,
vol. 18, no. 6, pp. 710–713, 2008.
[14] S. Nakagawa, H. Tagami, and S. Aiba, “Erythema multiforme-
like generalized contact dermatitis to l-menthol contained
in anti-inﬂammatory medical compresses as an ingredient,”
Contact Dermatitis, vol. 61, no. 3, pp. 178–179, 2009.
[15] T. Rind, N. Oiso, A. Hirao, and A. Kawada, “Allergic contact
dermatitis with diﬀuse erythematous reaction from Diiso-
propanolamine in a compress,” Case Reports in Dermatology,
vol. 2, no. 1, pp. 50–54, 2010.
[16] D. A. Basketter, M. Marriott, N. J. Gilmour, and I. R. White,
“Strong irritants masquerading as skin allergens: the case of
benzalkonium chloride,” Contact Dermatitis,v o l .5 0 ,n o .4 ,p p .
213–217, 2004.
[17] N. Oiso, K. Fukai, and M. Ishii, “Irritant contact dermatitis
frombenzalkoniumchlorideinshampoo,”ContactDermatitis,
vol. 52, no. 1, p. 54, 2005.
[18] W.Uter,H.Lessmann,J.Geier,andA.Schnuch,“Istheirritant
benzalkonium chloride a contact allergen? A contribution
to the ongoing debate from a clinical perspective,” Contact
Dermatitis, vol. 58, no. 6, pp. 359–363, 2008.
[19] S. Imai, K. Atarashi, K. Ikesue, K. Akiyama, and Y. Tokura,
“Establishment of murine model of allergic photocontact
dermatitis to ketoprofen and characterization of pathogenic
Tc e l l s , ”Journal of Dermatological Science, vol. 41, no. 2, pp.
127–136, 2006.
[20] K. Atarashi, K. Kabashima, K. Akiyama, and Y. Tokura,
“Stimulation of Langerhans cells with ketoprofen plus UVA
in murine photocontact dermatitis to ketoprofen,” Journal of
Dermatological Science, vol. 47, no. 2, pp. 151–159, 2007.
[21] N. Tanaka, A. Kawada, Y. Ohnishi et al., “Photosensitivity due
to doxycycline hydrochloride with an unusual ﬂare,” Contact
Dermatitis, vol. 37, no. 2, pp. 93–94, 1997.